Free Trial

Sanofi (SNY) SEC Filings & 10K Form

$57.73
-0.51 (-0.88%)
(As of 09/6/2024 ET)

Recent Sanofi SEC Filings

DateFilerForm TypeView
09/03/2024
9:46 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
8:06 AM
MeiraGTx Holdings plc (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC 13G/A
08/13/2024
5:30 AM
MeiraGTx Holdings plc (Issuer)
Sanofi (Reporting)
Sanofi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2024
5:05 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
10:43 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
9:26 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2024
10:28 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
1:25 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2024
3:22 PM
Sanofi (Filer)
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/28/2024
3:26 PM
Sanofi (Filer)
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/11/2024
12:54 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2024
3:30 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
11:04 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
9:34 AM
Sanofi (Filer)
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
05/02/2024
2:52 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
9:49 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
1:07 PM
Sanofi (Filer)
Sanofi (Filer)
Form F-3ASR
04/04/2024
7:45 AM
Sanofi (Filer)
Sanofi (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2024
1:07 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/15/2024
7:40 AM
Sanofi (Filer)
Sanofi (Filer)
Form S-8 POS
02/27/2024
10:35 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
1:02 PM
Sanofi (Filer)
Sanofi (Filer)
Form IRANNOTICE
02/23/2024
10:15 AM
Sanofi (Filer)
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/15/2024
11:09 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2024
12:55 PM
DODGE & COX (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SC 13G/A
02/06/2024
2:14 PM
BlackRock Inc. (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SC 13G/A
02/02/2024
12:21 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2024
8:45 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2024
6:23 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2024
12:49 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
10:18 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
9:39 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2023
4:23 PM
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form F-6EF
12/01/2023
11:19 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2023
6:50 AM
MeiraGTx Holdings plc (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC 13G
10/27/2023
11:39 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/27/2023
10:33 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/26/2023
6:16 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/20/2023
1:31 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2023
5:05 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2023
5:06 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Fmr CIA Advisor reveals PEACEMAKER superweapon (Ad)

Kamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.

Full details are in this announcement.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SNY) was last updated on 9/8/2024 by MarketBeat.com Staff

From Our Partners